Cannabis cultivator Hilltop Leaf received £2 million as part of a private investment to become one of the largest medical cannabis producers in the U.K., according to the Insider.
Hilltop Leaf founder Hamish Clegg noted how medicinal cannabis use is growing, but that the U.K. currently remains reliant on imports.
Founded in 2019, Hilltop Leaf aims to produce pharmaceutical-grade cannabis-based products for human medicinal use (CBPMs). It also has a research partnership with Nottingham Trent University, which specializes in clinical trials and testing.
The company plans to compete with suppliers in other countries such as Canada, Germany, and Israel.
Trending: Yes, Elon Musk Is Rich, And So Is Bill Gates: But Who Are The Wealthiest Women In The World?
In addition, the company has an 11,000 square-mile production facility and hopes to supply over 10% of the U.K. market.
© Provided by Benzinga portland.jpg
Image By Hilltop Leaf Via the Insider UK
APPLE INC.
0.00
0.00%
CONSTELLATION BRANDS, INC.
-2.99
-1.36%
TESLA, INC.
0.00
0.00%
AMAZON.COM, INC.
0.00
0.00%
In 2018, Great Britain legalized the medicinal use of marijuana being used by more than 20,000 patients in the U.K. However, around 1.8 million people in the U.K. use ‘black market’ cannabis to treat medical conditions, per the Centre for Medicinal Cannabis.
Get your daily dose of cannabis news on Benzinga Cannabis. Don’t miss out on any important developments in the industry.
Photo: Courtesy Of Matteo Paganelli On Unsplash
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
SPONSORED
Retirement can be a difficult part of life to navigate, and a financial advisor can help. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Recent Comments